Clinical trial
Suxiao Jiuxin Pills in Microvascular Obstruction in Patients With Acute Coronary Syndrome
NCT04814121 is registered in ClinicalTrials.gov with Guangzhou University of Traditional Chinese Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Suxiao Jiuxin Pills in Microvascular Obstruction in Patients With Acute Coronary Syndrome
- Lead sponsor
- Guangzhou University of Traditional Chinese Medicine
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- May 1, 2021
- Completion date
- September 30, 2023
- Enrollment
- 198 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.